PR Syndication Newsroom

Sat03252017

Last update02:15:27 AM GMT

Back Health Medical News Pharmaceutical

Pharmaceutical News

Online Database of Pharmacovigilance Requirements in over 100 countries on All Continents (GRID™)

PRINCETON, N.J., Aug. 4, 2014 /PRNewswire-iReach/ -- Pharmaceutical Regulatory Services, Inc. (PRS Inc.), a global provider of regulatory and pharmacovigilance support to the pharmaceutical, biotechnology and medical device industries, is pleased to announce the expansion  of GRID™...

Read more...

Halozyme to Host second Quarter 2014 Financial Results Conference Call

SAN DIEGO, Aug. 4, 2014 -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2014 on Monday, August 11, 2014 at 4:30 p.m. ET/1:30 p.m. PT. Dr. Helen Torley, President and Chief Executive Officer, will lead the call. On the same date post-market, Halozyme will...

Read more...

Diplomat signs agreement with oncology management firm Physician Resource Management, Inc. as preferred specialty pharmacy network provider

FLINT, Mich., Aug. 4, 2014 -- Diplomat, the nation's largest independent specialty pharmacy, has announced a partnership agreement with Physician Resource Management, Inc. (PRM). In this relationship, Diplomat will act as a preferred specialty pharmacy network provider. As a credentialed, preferred provider of specialty...

Read more...

Agreement on Phase 3 Trial Protocol of OSE Pharma's OSE-2101 From the FDA and EMA

PARIS, June 23, 2014 --

OSE Pharma SA receives a positive agreement to initiate a Phase 3 clinical trial with OSE-2101, a therapeutic cancer vaccine for non-small cell lung cancer (NSCLC) 

OSE Pharma SA, a European cancer immunotherapy company with a specific T cytotoxic technology, today announced that it has received...

Read more...

Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation with Cephalon, Inc. for its ANDA Bendamustine HCl Powder for IV (Treanda®)

BOCA RATON, Fla., June 23, 2014 -- Breckenridge Pharmaceutical, Inc.announced today that it has filed an ANDA with a Paragraph IV certification for bendamustine hydrochloride powder for IV (infusion), 25 mg/vial and 100 mg/vial, a generic version of Treanda® by Cephalon, Inc.  On May 27, 2014, Cephalon, Inc. filed a...

Read more...

EntreMed Stockholders Approve Name Change To CASI Pharmaceuticals

ROCKVILLE, Md., June 13, 2014 -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage biopharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that at its annual meeting of stockholders held on June 12, 2014, stockholders voted in favor of changing the company's corporate name...

Read more...

If Achillion Pharmaceuticals (NASDAQ: ACHN) Investors Are Hoping for a Buyout, This is Not an Investment Strategy; Analyst Report by BrokerBank Securities, Inc.

NEW YORK, June 13, 2014 -- Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is a biopharmaceutical company that is engaged in the discovery, development and commercialization of innovative treatments for infectious diseases. Within the anti-infective market, the company is primarily focused on developing commercially competitive...

Read more...

Sofie Biosciences Partners with PerkinElmer to Deliver Benchtop PET In Vivo Imaging Systems to Preclinical Research Professionals

CULVER CITY, Calif., June 13, 2014 -- Sofie Biosciences, a leader in the field of PET imaging, and PerkinElmer Inc., today announced an agreement in which PerkinElmer will exclusively commercialize and sell preclinical Positron Emission Tomography (PET) – X-Ray and 3-dimensional Computed Tomography (CT) imaging systems...

Read more...

Experimental antibody shows early promise for treatment of childhood tumor

MEMPHIS, Tenn., May 8, 2014 /PRNewswire-USNewswire/ -- Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody produced at St. Jude Children's Research Hospital. Four patients are still alive after more than two-and-a-half...

Read more...

MedSnap Launches Pharmaceutical Supply Chain Security Solution - MedSnap Verify Services

BIRMINGHAM, Ala., April 8, 2014 -- According to The World Health Organization 10 percent of medicines globally – and over 30 percent in some developing countries – are counterfeit, resulting in poor patient outcomes and decreased consumer confidence in pharmaceutical therapy. To help combat this public health...

Read more...